SCHEMBL31599989

SCHEMBL31599989

CCOc1cc2nn(C)nc2cc1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
PKM P14618 1/20 0.39
HSD17B10 Q99714 2/20 0.38
TSHR P16473 1/20 0.38
HPGD P15428 3/20 0.36
MAPT P10636 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 3/20 0.36
NPC1 O15118 1/20 0.34
CASP3 P42574 1/20 0.34
RAB9A P51151 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16431711 0.79 HPGD (0.43) LMNAL3MBTL1MEN1KMT2APKM
SCHEMBL31600919 0.79 MEN1 (0.46) LMNAL3MBTL1MEN1KMT2APKM
Hydrochloric Acid SCHEMBL31600226 0.77 MAPT (0.44) LMNAL3MBTL1MEN1KMT2APKM
SCHEMBL25186788 0.77 MAPT (0.39) LMNAL3MBTL1MEN1KMT2APKM
SCHEMBL16432160 0.76 L3MBTL1 (0.41) LMNAL3MBTL1MEN1KMT2APKM
SCHEMBL31600579 0.76 HTR2A (0.40) LMNAL3MBTL1MEN1KMT2APKM
SCHEMBL10967724 0.76 LMNA (0.57) LMNAL3MBTL1MEN1KMT2AHSD17B10
SCHEMBL16432256 0.71 GRM5 (0.37) LMNAL3MBTL1MEN1KMT2APKM
SCHEMBL16431781 0.71 GRM5 (0.37) LMNAL3MBTL1MEN1KMT2APKM
SCHEMBL16431851 0.71 HSD17B10 (0.48) LMNAL3MBTL1MEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025111547-A1 2,3-DIHYDROPYROLLOPYRIDINE CARBOXAMIDE COMPOUNDS AND METHODS OF USE THEREOF RGENTA THERAPEUTICS, INC. (US) 2025-05-30 WO disclosed